0001815337-25-000003.txt : 20251204
0001815337-25-000003.hdr.sgml : 20251204
20251204095403
ACCESSION NUMBER: 0001815337-25-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20251204
DATE AS OF CHANGE: 20251204
EFFECTIVENESS DATE: 20251204
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Triana Biomedicines, Inc.
CENTRAL INDEX KEY: 0001815337
ORGANIZATION NAME:
EIN: 843078067
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-565748
FILM NUMBER: 251548483
BUSINESS ADDRESS:
STREET 1: 1050 WALTHAM STREET
STREET 2: SUITE 301
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-317-4414
MAIL ADDRESS:
STREET 1: 1050 WALTHAM STREET
STREET 2: SUITE 301
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: Santi Therapeutics, Inc.
DATE OF NAME CHANGE: 20200617
D
1
primary_doc.xml
X0708
D
LIVE
0001815337
Triana Biomedicines, Inc.
1050 WALTHAM STREET
SUITE 301
LEXINGTON
MA
MASSACHUSETTS
02421
781-317-4414
DELAWARE
Santi Therapeutics, Inc.
Corporation
true
Patrick
Trojer
1050 Waltham Street
Suite 301
Lexington
MA
MASSACHUSETTS
02421
Executive Officer
Director
David
Grayzel
1050 Waltham Street
Suite 301
Lexington
MA
MASSACHUSETTS
02421
Director
Joshua
Resnick
1050 Waltham Street
Suite 301
Waltham
MA
MASSACHUSETTS
02421
Director
Jigar
Raythatha
1050 Waltham Street
Suite 301
Waltham
MA
MASSACHUSETTS
02421
Director
Christopher
O'Donnell
1050 Waltham Street
Suite 301
Lexington
MA
MASSACHUSETTS
02421
Director
Shelley
Chu
1050 Waltham Street
Suite 301
Lexington
MA
MASSACHUSETTS
02421
Director
Lorence
Kim
1050 Waltham Street
Suite 301
Lexington
MA
MASSACHUSETTS
02421
Director
Andrew
Hedin
1050 Waltham Street
Suite 301
Lexington
MA
MASSACHUSETTS
02421
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2025-11-26
false
true
false
0
120061960
120061960
0
false
20
0
0
0
false
Triana Biomedicines, Inc.
/s/ Patrick Trojer
Patrick Trojer
President
2025-12-04